AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+8.3%
5Y CAGR+6.4%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+8.3%/yr
vs +12.4%/yr prior
5Y CAGR
+6.4%/yr
Consistent
Acceleration
-4.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $45.47B | +12.5% |
| 2024 | $40.43B | +10.6% |
| 2023 | $36.56B | +2.3% |
| 2022 | $35.75B | -2.3% |
| 2021 | $36.58B | +9.7% |
| 2020 | $33.33B | +21.7% |
| 2019 | $27.39B | +22.2% |
| 2018 | $22.41B | +21.5% |
| 2017 | $18.45B | +15.2% |
| 2016 | $16.02B | - |